Pre-Market Alert – 4 Stocks High On Our Watchlist Today

NEW YORK, NY / ACCESSWIRE / April 8, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. SUNE, CLRB, TPIV and SKYS are on high volume alert. Continue reading to find out why these stocks are getting so much interest today. – If you want reports on the day’s hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.

SunEdison, Inc. (NYSE: SUNE) For those of you following us, as you know, we’ve been watching SUNE all week this week as it continues to try to work out of its financial, managerial and legal woes.

However, as the news continues to unfold, SUNE continues to move higher, making gains in the last 3 days.

SUNE is a renewable energy development company, develops, finances, installs, owns, and operates renewable power plants to residential, commercial, government, and utility customers.

The solar industry is seeing much needed improvement that has been noted in 2015 and is continuing into 2016 and we have our watch lists set to pick up any companies gaining major volume in this surging sector.

Shares of SUNE closed up two days ago by over 42% and made even more gains yesterday, up another 8%.

Rosen Law Firm Announced Investigation of Securities Claims Against SunEdison, Inc. (SUNE) on Behalf of Vivint Solar, Inc. (VSLR) Shareholders two days ago. And, yesterday, Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Vivint Solar, Inc. (VSLR).

These investigations are based on claims that SUNE may have misled the investing public regarded the proposed merger of SUNE and VSLR.

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Cellectar Biosciences, Inc. (NASDAQ: CLRB) is a biopharmaceutical company, develops compounds for the treatment, diagnosis, and imaging of cancer.

Shares of CLRB traded higher yesterday, after receiving a positive Nasdaq listing determination, yesterday.

We are adding CLRB to our watchlist to see if the incredible increase in recent volume can turn this troubled biotech around. Yesterday, CLRB traded almost 28 times its average volume.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

TapImmune, Inc. (OTCQB: TPIV) Is a clinical-stage immunotherapy company, develops peptide and gene-based immuno-therapeutics and vaccines for the treatment of cancer and infectious diseases.

Yesterday TPIV announced that it has successfully completed formulation development, scale-up, GMP (Good Manufacturing Practice) manufacturing, and the release of TPIV 200, its multi-epitope folate receptor peptide vaccine for breast and ovarian cancer.

While TPIV traded in the red all day yesterday, we expect to see the stock perform better in the near future.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

Sky Solar Holdings, Ltd. (NASDAQ: SKYS) Is an independent power producer, develops, owns, and operates solar parks worldwide. It develops projects; and generates and sells electricity in the downstream solar market.

We first reported to you on SKYS, three days ago, after it had a couple days of massive volume and big gains. Since then, it has cooled off a bit, however, we are still watching it to see if it can continue in its uptrend.

After having another big day yesterday, we want to see if SKYS will make another big short-term move.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About otc-expert.com

The OTC Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “OTCLEADER”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The OTC Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The OTC Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit otc-expert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The OTC Expert
info@otc-expert.com

SOURCE: The OTC Expert

ReleaseID: 438597